REAL

Items where Author is "Maj-Hes, Agnieszka"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.

Article

Csizmarik, Anita and Keresztes, Dávid and Nagy, Nikolett and Bracht, Thilo and Sitek, Barbara and Witzke, Kathrin and Puhr, Martin and Tornyi, Ilona and Tímár, József and Takács, László and Kramer, Gero and Sevcenco, Sabina and Maj-Hes, Agnieszka and Jurányi, Zsolt and Hadaschik, Boris and Nyirády, Péter and Szarvas, Tibor (2022) Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer. INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136

Maj-Hes, Agnieszka and Szarvas, Tibor and Sevcenco, Sabina and Kramer, Gero (2021) Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival. Advances in Therapy, 38. pp. 3831-3841. ISSN 1865-8652

Szarvas, Tibor and Csizmarik, Anita and Váradi, Melinda and Fazekas, Tamás and Hüttl, András and Nyirády, Péter and Hadaschik, Boris and Grünwald, Viktor and Tschirdewahn, Stephan and Shariat, Shahrokh F and Sevcenco, Sabina and Maj-Hes, Agnieszka and Kramer, Gero (2021) The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy. Urologic Oncology, 39 (5). 296.e11-296.e19. ISSN 1078-1439

Maj-Hes, Agnieszka and Sevcenco, Sabina and Szarvas, Tibor and Kramer, Gero (2019) Claros System: A Rapid Microfluidics-Based Point-of-Care System for Quantitative Prostate Specific Antigen Analysis from Finger-Stick Blood. Advances in Therapy, 36 (4). pp. 916-922. ISSN 1865-8652

Darr, Christopher and Krafft, Ulrich and Hadaschik, Boris and Tschirdewahn, Stephan and Sevcenco, Sabina and Csizmarik, Anita and Nyirády, Péter and Küronya, Zsófia and Reis, Henning and Maj-Hes, Agnieszka and Shariat, Shahrokh F and Kramer, Gero and Szarvas, Tibor (2018) The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer. UROLOGIA INTERNATIONALIS, 101 (1). ISSN 0042-1138

This list was generated on Thu Apr 25 01:25:30 2024 CEST.